Literature DB >> 25515196

A Prospective Evaluation of Lymphedema-Specific Quality-of-Life Outcomes Following Vascularized Lymph Node Transfer.

Ketan M Patel1, Chia-Yu Lin, Ming-Huei Cheng.   

Abstract

BACKGROUND: Microsurgical techniques for the treatment of lymphedema rapidly increased in popularity. Although surgical success with vascularized lymph node (VLN) transfer has been demonstrated, limited studies have investigated the influence of microsurgical treatments on health-related quality-of-life (HRQoL) parameters. The aim of this study was to prospectively evaluate changes in HRQoL following VLN transfer for upper- and lower-extremity lymphedema using a validated instrument.
METHODS: An Institutional Review Board-approved prospective study was performed of patients who underwent VLN transfer for symptomatic upper- or lower-limb lymphedema. A validated lymphedema-specific questionnaire-lymphoedema quality-of-life study-was utilized to assess specific quality-of-life parameters at multiple time points during the 12-month perioperative period. For a comparison with HRQoL metrics, limb circumference measurements were obtained to assess circumference differentiation.
RESULTS: Twenty-five patients met the study criteria. Limb circumference analysis revealed significant early improvements following VLN transfer, with continued improvement during the study period (upper-limb lymphedema: 24.4 %; lower-limb lymphedema: 35.2 %). These improvements were mirrored by improvements in all HRQoL domains and overall quality of life (p < 0.01). The function, body appearance, symptom, and mood domains were all found to be significantly improved during the postoperative evaluation, with continued improvement being reported throughout the study period (p < 0.01 within each domain).
CONCLUSIONS: Microsurgical treatment of lymphedema with VLN transfer procedures effectively decrease limb circumference. This improvement is mirrored by improvements in patient-reported outcomes and quality of life. These changes can be observed as soon as 1 month postoperatively, and continued steady improvement can be expected.

Entities:  

Mesh:

Year:  2014        PMID: 25515196     DOI: 10.1245/s10434-014-4276-3

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  25 in total

1.  Prevention of Postsurgical Lymphedema by 9-cis Retinoic Acid.

Authors:  Athanasios Bramos; David Perrault; Sara Yang; Eunson Jung; Young Kwon Hong; Alex K Wong
Journal:  Ann Surg       Date:  2016-08       Impact factor: 12.969

Review 2.  Lymphaticovenular anastomosis for breast cancer-related upper extremity lymphedema: a literature review.

Authors:  Antonio J Forte; Andrea Sisti; Maria T Huayllani; Daniel Boczar; Gabriela Cinotto; Pedro Ciudad; Oscar J Manrique; Xiaona Lu; Sarah McLaughlin
Journal:  Gland Surg       Date:  2020-04

Review 3.  Lymphatic mapping and lymphedema surgery in the breast cancer patient.

Authors:  Ketan M Patel; Oscar Manrique; Michael Sosin; Mahjabeen Aftab Hashmi; Poysophon Poysophon; Robert Henderson
Journal:  Gland Surg       Date:  2015-06

4.  A Prospective Study on the Safety and Efficacy of Vascularized Lymph Node Transplant.

Authors:  Stav Brown; Babak J Mehrara; Michelle Coriddi; Leslie McGrath; Michele Cavalli; Joseph H Dayan
Journal:  Ann Surg       Date:  2022-07-15       Impact factor: 13.787

5.  Translation and Validation of the Turkish Version of Lymphedema Quality of Life Tool (LYMQOL) in Patients with Breast Cancer Related Lymphedema.

Authors:  Yeşim Bakar; Alper Tuğral; Özlem Özdemir; Elif Duygu; Ümmügül Üyetürk
Journal:  Eur J Breast Health       Date:  2017-07-01

6.  MRI staging of upper extremity secondary lymphedema: correlation with clinical measurements.

Authors:  Geunwon Kim; Martin P Smith; Kevin J Donohoe; Anna Rose Johnson; Dhruv Singhal; Leo L Tsai
Journal:  Eur Radiol       Date:  2020-03-27       Impact factor: 5.315

Review 7.  Vascularized Lymph Node Transfer for Lymphedema.

Authors:  Mark V Schaverien; Ido Badash; Ketan M Patel; Jesse C Selber; Ming-Huei Cheng
Journal:  Semin Plast Surg       Date:  2018-04-09       Impact factor: 2.314

8.  Symptom Frequency, Intensity, and Distress in Patients with Lower Limb Lymphedema.

Authors:  Deonni P Stolldorf; Mary S Dietrich; Sheila H Ridner
Journal:  Lymphat Res Biol       Date:  2016-01-29       Impact factor: 2.589

9.  Treatment of end-stage lymphedema following radiotherapy for lymphoma: A case report.

Authors:  Kyung-Chul Moon; In-Jae Yoon
Journal:  Medicine (Baltimore)       Date:  2021-05-14       Impact factor: 1.889

Review 10.  Breast Cancer-Related Lymphedema: Recent Updates on Diagnosis, Severity and Available Treatments.

Authors:  Marco Pappalardo; Marta Starnoni; Gianluca Franceschini; Alessio Baccarani; Giorgio De Santis
Journal:  J Pers Med       Date:  2021-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.